GlassScriptPhysician profile
Jose Rodriguez
NPI 1477544591
$2,661.89
in general payments reported to CMS, 2019-2025
20 companies · $59.16 in 2025
The $59.16 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,098 · 2020: $327 · 2021: $424 · 2022: $345 · 2023: $146 · 2024: $262 · 2025: $59.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $791.58 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $488.20 | 2019-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $372.73 | 2019-2024 | Bexsero |
| Takeda Pharmaceuticals U.S.A., INC. | $201.44 | 2021-2022 | |
| Cranial Technologies, INC | $194.10 | 2019-2024 | Doc Band |
| Sanofi Pasteur INC. | $132.03 | 2022-2025 | |
| Kaleo, INC. | $108.11 | 2019-2023 | Auvi-Q |
| Sanofi-Aventis U.S. LLC | $60.72 | 2024-2025 | |
| Pfizer INC. | $48.59 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $42.12 | 2021-2023 | |
| Shire North American Group INC | $36.24 | 2019 | |
| Genentech USA, INC. | $34.99 | 2019-2020 | |
| Abbvie INC. | $28.92 | 2021 | |
| Aytu Biopharma, INC. | $22.76 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $22.49 | 2023 | Flumist Quadrivalent |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $21.54 | 2022 | |
| Phadia US INC. | $15.63 | 2020 | |
| Mylan Pharmaceuticals INC. | $13.94 | 2019 | |
| Tris Pharma INC | $13.38 | 2021 | |
| Corium, LLC | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.